ArticleJournal of robotic surgery2026
Effect of combined acetaminophen and nefopam on postoperative pain in patients undergoing robot-assisted urological surgery: a retrospective propensity score-matched analysis.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The acetaminophen-nefopam combination has not been investigated as a preventive analgesic strategy for robot-assisted urological surgery. Here, we evaluated whether their administration could reduce postoperative pain and opioid consumption in such patients. This retrospective cohort study analyzed adults who underwent robot-assisted urological surgery from April 2023 to March 2025 at a single tertiary academic center. Patients received conventional anesthetic management (conventional group) or preventive acetaminophen (1000 mg) and nefopam (20 mg) at robotic system de-docking (preventive group). Propensity score matching (1:1) was performed using the ASA physical performance class, surgery type, surgeon, and procedure duration. Pain was assessed using an 11-point numeric rating scale. The primary outcome was pain severity distribution upon postanesthesia care unit (PACU) arrival. After matching, 340 patients (170 per group) were analyzed. The preventive group exhibited higher proportions of patients with no/mild pain (57.6% vs. 29.4%, P < 0.001) and lower proportions with moderate pain (20.0% vs. 40.6%, P < 0.001) compared to the conventional group. Opioid-free analgesia rates were higher in the preventive group during PACU stay (36.5% vs. 16.5%, P < 0.001) and in the first 24 h (30.6% vs. 13.5%, P < 0.001). Rescue opioid consumption was lower in the preventive group during the PACU (2.5 vs. 7.5 mg morphine equivalent, P < 0.001) and 24-h periods (5 vs. 10 mg, P < 0.001). Their PACU stay was also shorter (34 vs. 40.5 min, P < 0.001). Preventive acetaminophen-nefopam administration was associated with significantly lower postoperative pain severity and opioid requirements and faster recovery after robot-assisted urological surgery.
Indexed as
Identifiers
41618013What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.